Skip to main content

Table 3 Univariate and multivariate analyses for survival in CRC patients after capecitabine therapy

From: CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients

Prognostic parameter Univariate analysis Multivariate analysis
HR 95%CI p value HR 95%CI p value
CD16 expression 0.395 0.194–0.808 0.011 2.130 0.227–0.998 0.049
Gender 1.049 0.534–2.064 0.889
Age 0.768 0.393–1.501 0.441
Tumor location 0.911 0.469–1.768 0.783
Tumor size 1.102 0.567–2.144 0.774
CEA 2.410 1.093–5.313 0.029 1.868 0.831–4.201 0.131
CA199 1.624 0.674–3.914 0.280
TNM 1.443 0.707–2.947 0.314
Recurrence 2.516 1.207–5.243 0.014 2.130 1.012–4.484 0.046
  1. HR Hazard ratio, CI Confident interval